Michael Weintraub

Michael is Managing Partner of Optum Ventures, focused on digital health innovation.  Previously, he was Co-Founder and CEO of Humedica, acquired by UnitedHealth Group (UHG) in 2013.  Michael broadened his role within UHG as President and CEO of Optum Analytics.  Prior to launching Humedica, he served as Senior Managing Director at Leerink Partners, a leading health care investment bank.  Previously, Michael was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005.  He serves as Founding Chairman of the Board of Phreesia, a digital health company that develops automated patient engagement solutions.  Michael is on the Board of Directors of Shyft Analytics, a company providing cloud data management and analytics solutions for global life sciences. He is on the Board of Directors of Mindstrong, a company transforming the diagnosis and treatment of behavioral health disorders through ubiquitous mobile technology. Michael is an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital.  Michael is a member of the Board of Directors of Juvenile Diabetes Research Foundation (JDRF) New England Chapter; as well as The College Diabetes Network (CDN), whose mission is to empower and improve the lives of students living with Type 1 diabetes through peer support and access to information and resources. Michael received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.